Skip to content

Evaluating the effects of using an ancillary method for performing intraarticular injections in patients with knee osteoarthritis

Comparison of therapeutic effects of intraarticular Hyaluronic acid injections with and without ultrasound guidance in patients with moderate knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201401043217N8
Enrollment
40
Registered
2014-01-31
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis. Generalized osteoarthritis NOS

Interventions

Intervention 1: In intervention group, the route will be first defined and confirmed by using ultrasound and the the injection will be performed. Intervention 2: In the control group injection will be
Treatment - Drugs
In intervention group, the route will be first defined and confirmed by using ultrasound and the the injection will be performed.
In the control group injection will be performed in superior lateral part without using other instruments.

Sponsors

Vice Chancellor for research of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 50 and 80 years old; grade 2 or 3 knee osteoarthritis based on Kellgren and Lawrence grading scale; not having any rheumatologic diseases; not responding to conservative medical therapies. Exclusion criteria: Receiving corticosteroids.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain severity at rest. Timepoint: Before starting the study and two months after the third injection. Method of measurement: Using visual analogue scale.;Knee's range of motion. Timepoint: Before starting the study and two months after the third injection. Method of measurement: By using goniometry.;Pain severity while moving. Timepoint: Before starting the study and two months after the third injection. Method of measurement: Using visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Roja Javadi

Tabriz University of Medical Sciences

roja.javadi@yahoo.com+98 41 1337 3967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026